Successful treatment of Epstein-Barr virus encephalitis in the setting of HIV-associated neurocognitive disorder: a diagnostic and therapeutic challenge

Research output: Contribution to journalArticleOther

6 Citations (Scopus)

Abstract

We report a challenging case of HIV-associated neurocognitive disorder with superimposed Epstein-Barr virus (EBV) encephalitis. The patient presented with an abnormal MRI brain scan, and EBV DNA that was detected in the cerebrospinal luid and brain biopsy, which also demonstrated histopathological indings consistent with the diagnosis. This occurred on the background of a 12-month period of gradual cognitive decrease secondary to HIV-associated dementia. Invasive testing was required to reach the diagnosis in this case, highlighting the importance of thorough investigation of neurological impairment in HIV-positive patients. Clinicopathological recovery was achieved through optimization of antiretroviral therapy and use of valganciclovir.
Original languageEnglish
Pages (from-to)257 - 261
Number of pages5
JournalAntiviral Therapy
Volume18
Issue number2
DOIs
Publication statusPublished - 2013

Cite this

@article{3b23495b2bfc4e70883bc701d9490fe7,
title = "Successful treatment of Epstein-Barr virus encephalitis in the setting of HIV-associated neurocognitive disorder: a diagnostic and therapeutic challenge",
abstract = "We report a challenging case of HIV-associated neurocognitive disorder with superimposed Epstein-Barr virus (EBV) encephalitis. The patient presented with an abnormal MRI brain scan, and EBV DNA that was detected in the cerebrospinal luid and brain biopsy, which also demonstrated histopathological indings consistent with the diagnosis. This occurred on the background of a 12-month period of gradual cognitive decrease secondary to HIV-associated dementia. Invasive testing was required to reach the diagnosis in this case, highlighting the importance of thorough investigation of neurological impairment in HIV-positive patients. Clinicopathological recovery was achieved through optimization of antiretroviral therapy and use of valganciclovir.",
author = "Trevillyan, {Janine Maree} and Mahony, {Andrew A} and McLean, {Catriona Ann} and Hoy, {Jennifer F}",
year = "2013",
doi = "10.3851/IMP2451",
language = "English",
volume = "18",
pages = "257 -- 261",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press",
number = "2",

}

TY - JOUR

T1 - Successful treatment of Epstein-Barr virus encephalitis in the setting of HIV-associated neurocognitive disorder: a diagnostic and therapeutic challenge

AU - Trevillyan, Janine Maree

AU - Mahony, Andrew A

AU - McLean, Catriona Ann

AU - Hoy, Jennifer F

PY - 2013

Y1 - 2013

N2 - We report a challenging case of HIV-associated neurocognitive disorder with superimposed Epstein-Barr virus (EBV) encephalitis. The patient presented with an abnormal MRI brain scan, and EBV DNA that was detected in the cerebrospinal luid and brain biopsy, which also demonstrated histopathological indings consistent with the diagnosis. This occurred on the background of a 12-month period of gradual cognitive decrease secondary to HIV-associated dementia. Invasive testing was required to reach the diagnosis in this case, highlighting the importance of thorough investigation of neurological impairment in HIV-positive patients. Clinicopathological recovery was achieved through optimization of antiretroviral therapy and use of valganciclovir.

AB - We report a challenging case of HIV-associated neurocognitive disorder with superimposed Epstein-Barr virus (EBV) encephalitis. The patient presented with an abnormal MRI brain scan, and EBV DNA that was detected in the cerebrospinal luid and brain biopsy, which also demonstrated histopathological indings consistent with the diagnosis. This occurred on the background of a 12-month period of gradual cognitive decrease secondary to HIV-associated dementia. Invasive testing was required to reach the diagnosis in this case, highlighting the importance of thorough investigation of neurological impairment in HIV-positive patients. Clinicopathological recovery was achieved through optimization of antiretroviral therapy and use of valganciclovir.

UR - http://www.scopus.com/record/display.url?eid=2-s2.0-84875661491&origin=resultslist&sort=plf-f&src=s&st1=Successful+treatment+of+Epstein-Barr+virus+enc

U2 - 10.3851/IMP2451

DO - 10.3851/IMP2451

M3 - Article

VL - 18

SP - 257

EP - 261

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 2

ER -